Flagship Ventures Opportunities Fund I, L.P.
Insider CIK 1677345 · AXLA 10% owner · EVLO 10% owner · RUBY 10% owner · KLDO 10% owner · FHTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 2,235,468 | $6.71 | $15.00M | 2,235,468 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-10-13 | 2022-10-17 | 914,634 | $1.64 | $1.50M | 5,380,500 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-10-13 | 2022-10-17 | 2,743,902 | $1.64 | $4.50M | 11,344,305 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-10-13 | 2022-10-17 | 2,757,333 | $1.64 | $4.52M | 14,101,638 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-10-13 | 2022-10-17 | 919,111 | $1.64 | $1.51M | 6,299,611 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-10-13 | 2022-10-17 | 3,048,780 | $1.64 | $5.00M | 3,048,780 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 4,383,561 | $1.46 | $6.40M | 7,590,873 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 13,698,630 | $1.46 | $20.00M | 13,698,630 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,369,863 | $1.46 | $2.00M | 5,495,324 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 1,095,890 | $1.46 | $1.60M | 1,887,419 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2022-05-27 | 2022-06-01 | 6,849,315 | $1.46 | $10.00M | 8,219,791 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 947,905 | $1.91 | $1.81M | 2,004,657 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 3,791,623 | $1.91 | $7.24M | 8,600,403 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2022-03-16 | 2022-03-18 | 1,579,843 | $1.91 | $3.02M | 4,465,866 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 15,393,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 5,859,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | P Buy | 2021-03-19 | 2021-03-23 | 70,000 | $29.00 | $2.03M | 2,633,703 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,667 | $11.50 | $824.2K | 738,333 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,667 | $11.50 | $824.2K | 2,982,639 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2021-02-08 | 2021-02-10 | 71,666 | $11.50 | $824.2K | 1,685,444 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 1,370,476 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 46,429 | $15.00 | $696.4K | 4,125,461 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 37,143 | $15.00 | $557.1K | 3,207,312 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2021-02-02 | 2021-02-04 | 9,285 | $15.00 | $139.3K | 791,529 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 2,666,666 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 1,336,293 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 3,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 8,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 7,500,000 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 9,330,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,504,504 | — | $0 | 8,558,558 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,054,054 | — | $0 | 4,054,054 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,441,441 | — | $0 | 1,441,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,491,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 722,320 | — | $0 | 9,280,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,801,801 | — | $0 | 1,801,801 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,851,801 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,666,667 | $3.75 | $6.25M | 4,079,032 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,333,333 | $3.75 | $5.00M | 1,333,333 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 333,333 | $3.75 | $1.25M | 782,244 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2020-06-29 | 2020-07-01 | 1,333,333 | $3.75 | $5.00M | 3,170,169 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 666,667 | $7.50 | $5.00M | 1,613,778 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 666,667 | $7.50 | $5.00M | 2,910,972 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2020-06-04 | 2020-06-08 | 666,666 | $7.50 | $5.00M | 666,666 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 380,000 | $4.75 | $1.80M | 1,056,752 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 1,900,000 | $4.75 | $9.03M | 2,886,023 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2020-05-18 | 2020-05-20 | 1,520,000 | $4.75 | $7.22M | 4,808,780 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 895,255 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 89,525 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 358,102 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 151,643 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 617,914 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 222,506 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,005,413 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,384,615 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 4,153,847 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 928,074 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 386,697 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 751,691 | — | $0 | 1,430,301 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2019-05-13 | 2019-05-15 | 500,000 | $20.00 | $10.00M | 986,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 486,023 | — | $0 | 486,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 48,602 | — | $0 | 676,752 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 194,409 | — | $0 | 3,288,780 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 82,324 | — | $0 | 628,150 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 335,457 | — | $0 | 3,094,371 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 120,795 | — | $0 | 1,761,029 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 2,255,074 | — | $0 | 2,255,074 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 503,840 | — | $0 | 2,758,914 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 209,933 | — | $0 | 1,640,234 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 545,826 | — | $0 | 545,826 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,251,251 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,251,251 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 2,570,694 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,928,021 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 642,674 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,278,720 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 852,480 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 9,275,111 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 3,091,704 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 426,240 | — | $0 | 1,972,092 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 333,333 | $15.00 | $5.00M | 2,244,305 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 625,625 | — | $0 | 6,227,190 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 1,285,347 | — | $0 | 1,285,347 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 964,010 | — | $0 | 5,601,565 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 321,337 | — | $0 | 2,293,429 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 639,360 | — | $0 | 639,360 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 625,625 | — | $0 | 1,910,972 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 4,637,555 | — | $0 | 4,637,555 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 1,545,852 | — | $0 | 1,545,852 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 266,667 | $15.00 | $4.00M | 2,560,096 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | P Buy | 2019-03-04 | 2019-03-06 | 333,333 | $15.00 | $5.00M | 6,560,523 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 3,830,402 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 15,323,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 2,563,703 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 1,781,843 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 4,643,963 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 18,611,110 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 8,333,000 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 5,416,667 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 10,102,055 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 12,536,945 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-15 | 14,622,143 | — | $0 | 17,952,153 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 281,250 | $16.00 | $4.50M | 18,233,403 | SEC↗ |